Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine and Discipline of Psychiatry, Trinity College Dublin, Dublin, Ireland.
School of Biotechnology, Dublin City University, Dublin, Ireland.
Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):223-231. doi: 10.1002/ajmg.b.32716. Epub 2019 Feb 23.
Genome-wide association studies (GWASs) are highly effective at identifying common risk variants for schizophrenia. Rare risk variants are also important contributors to schizophrenia etiology but, with the exception of large copy number variants, are difficult to detect with GWAS. Exome and genome sequencing, which have accelerated the study of rare variants, are expensive so alternative methods are needed to aid detection of rare variants. Here we re-analyze an Irish schizophrenia GWAS dataset (n = 3,473) by performing identity-by-descent (IBD) mapping followed by exome sequencing of individuals identified as sharing risk haplotypes to search for rare risk variants in coding regions. We identified 45 rare haplotypes (>1 cM) that were significantly more common in cases than controls. By exome sequencing 105 haplotype carriers, we investigated these haplotypes for functional coding variants that could be tested for association in independent GWAS samples. We identified one rare missense variant in PCNT but did not find statistical support for an association with schizophrenia in a replication analysis. However, IBD mapping can prioritize both individual samples and genomic regions for follow-up analysis but genome rather than exome sequencing may be more effective at detecting risk variants on rare haplotypes.
全基因组关联研究(GWAS)在识别精神分裂症的常见风险变异方面非常有效。罕见风险变异也是精神分裂症病因的重要贡献者,但除了大片段拷贝数变异外,GWAS 很难检测到这些变异。外显子组和基因组测序加速了对罕见变异的研究,但这些方法昂贵,因此需要替代方法来帮助检测罕见变异。在这里,我们通过对被鉴定为共享风险单倍型的个体进行亲缘关系(IBD)作图和外显子组测序,对一个爱尔兰精神分裂症 GWAS 数据集(n=3473)进行了重新分析,以搜索编码区域中的罕见风险变异。我们确定了 45 个罕见单倍型(>1 cM),这些单倍型在病例中比对照组更为常见。通过对 105 个单倍型携带者进行外显子组测序,我们研究了这些单倍型中的功能编码变异,这些变异可以在独立的 GWAS 样本中进行关联测试。我们在 PCNT 中发现了一个罕见的错义变异,但在复制分析中没有发现与精神分裂症关联的统计学支持。然而,IBD 作图可以优先对个体样本和基因组区域进行后续分析,但在检测罕见单倍型上,全基因组测序可能比外显子组测序更有效。